Company profile
(169K PDF)
media
Media interview
4 August 2005
Interview With: Dr. Clive Dix, Ph.D. Chief Executive Officer
RealPlayer required -
click here
to download
Conferences sponsored by PowderMed
21 - 23 March 2006
DNA Vaccination by Gene Gun - Magdalen College, Oxford
Press releases
1 August 2005
Powdermed Manufactures a Vaccine Against H5n1 (Avian Influenza) for Clinical Development
20 February 2005
Rolf Stahel Appointed as Chairman of PowderMed
18 November 2004
Positive outcome of Phase I DNA Influenza Study - PowderMed announces first clinical trial results
8 November 2004
PowderMed appoints Adam Christie as Chief Business Officer
16 October 2004
PowderMed initiate a Phase I clinical trial for a novel therapeutic Herpes Simplex type 2 (HSV2) DNA vaccine
17 September 2004
Ludwig Institiute for Cancer Research and PowderMed initiate a Phase I clinical trial for a novel therapeutic cancer vaccine
17 May 2004
PowderMed launched in spin out of powder injection DNA vaccine programmes from Chiron Vaccines
Press materials
Corporate factsheet
(260k PDF)
Japanese factsheet
(940k PDF)